{"SPADE_N_13740": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_13740", "Peptide Name": "Bogorol L (natural AMPs; nonribosomal peptide; bogorol family, Val-rich; lipopeptide, XXL; XXW1, XXD1; bacteria, prokaryotes)", "Source": "Brevibacillus laterosporusMG64", "Family": "Not found", "Gene": "Not found", "Sequence": "TVKIIVKVVKYLV", "Sequence Length": 13, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 1501.94, "PI": 10.0, "Hydrophobicity": 1.55, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Li Z, de Vries RH, Chakraborty P, Song C, Zhao X, Scheffers DJ, Roelfes G, Kuipers OP. 2020", "Reference": "Appl Environ Microbiol. 2020 Nov 24;86(24):e01981-20. doi: 10.1128/AEM.01981-20.PubMed", "Title": "Novel Modifications of Nonribosomal Peptides from Brevibacillus laterosporus MG64 and Investigation of Their Mode of Action."}], "Frequent Amino Acids": "VKI", "Absent Amino Acids": "ACDEFGHMNOPQRSUW", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 10, "Positive Residues": 3, "Negative Residues": 0, "Net Charge": 3, "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (92.31%) toBogorol KChemical modification:  N-terminus is acylated with 2-hydroxy-3-methylvaleric acid (lipo); T1 dehydrated (Dhb); R3 and Y11 are D-amino acids; C-terminus is a characteristic valinol (an alcohol form of valine).Activity:  active against X. campestris pv. campestris NCCB92058 (MIC 2 ug/ml), X. translucens pv. graminis LMG587 (MIC 4 ug/ml), P. syringae pv. antirrhini LMG2131, P. syringae pv. tomato DC3000 (MIC 8 ug/ml), P. aeruginosa PAO1 (MIC 32 ug/ml), K. pneumoniae LMG20218 (MIC 32 ug/ml), E. coli ET8 or MG1665 (MIC 8-16 ug/ml),  P-carotovorum LMG5863 (MIC>32 ug/ml), R. syzygii subsp. syzygii LMG6969 (MIC 32 ug/ml), S. aureus subsp. aureus 533 R4, B. cereus ATCC 14579, E. faecium LMG16003 (MIC 2 ug/ml).Updated 6/2024", "Similar Sequences": [{"SPADE_ID": "SPADE_N_15517", "Similarity": 1.0, "Sequence": "VKIIVKVVKYL"}, {"SPADE_ID": "SPADE_N_13741", "Similarity": 0.9230769230769231, "Sequence": "TLKIIVKVVKYLV"}, {"SPADE_ID": "SPADE_N_13739", "Similarity": 0.9230769230769231, "Sequence": "TVRIIVKVVKYLV"}]}}}